Viewing Study NCT07426432


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 12:20 AM
Study NCT ID: NCT07426432
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2026-02-23
First Post: 2025-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Effect of Fluoride-Releasing Composite Resin on Prevention of White Spot Lesions During Clear Aligner Therapy
Sponsor: Mansoura University
Organization:

Study Overview

Official Title: Evaluate the Effect of Fluoride-Releasing Composite Resin on Prevention of White Spot Lesions During Clear Aligner Therapy: A Controlled Split-Mouth Study
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2026-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Aim of this study: evaluate the effect of fluoride-releasing composite resin as attachments on prevention of white spot lesions.

Material and methods:

Type: Prospective, randomized split mouth controlled study.

Interventions:

Intervention Group (Experimental Side):

•Application of fluoride-releasing composite

Control Group (Control Side):

•Application of conventional composite

Outcome Measures:

Primary Outcome: Incidence and Severity of White Spot Lesions

Secondary Outcomes:

1. Periodontal Ligament (PDL) Health
2. Gingival Bleeding and Inflammation
Detailed Description: Aim of the Study:

The aim of this study is to evaluate the effect of fluoride-releasing composite resin as attachments on prevention of white spot lesions (WSLs) development during clear aligner therapy in comparison to a split-mouth controlled group.

Material and methods:

Study Design:

Each participant will have one side of the mouth assigned to fluoride-releasing composite intervention as attachments, while the contralateral side will be assigned to conventional composite as attachments.

Sample size calculation:

Sample size calculation was based on effect of fluoride-releasing composite resin on prevention of White Spot Lesions during Clear Aligner Therapy: that was retrieved from most similar research Abdullah et al. Using G power program version 3.1.9.7 to calculate sample size based on effect size of 1.08 that is based on mean area of white spots, using 2-tailed test, α error = 0.05 and power = 95% , the total calculated sample size will be 24 in each group. To mitigate the potential impact of an anticipated 20% dropout rate, the recruitment target was increased to 30 patients per treatment group, aiming to ensure adequate statistical power in the final analyzed sample.

Inclusion Criteria:

* Patients aged 16-24 years.
* Good general and oral health.
* Mild dental crowding per arch (≤ 4 mm).

Exclusion Criteria:

* Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders).
* Patients with Cleft lip and palate.
* Previous orthodontic treatment.
* Dental fluorosis.
* Hypocalcified teeth or visible demineralization.

Interventions:

1. Initial Oral Scan:

A 3D oral scan of the arch to be treated will be performed using a digital intraoral scanner
2. Aligner Fabrication:

Aligners will be fabricated using thermoforming techniques. Intervention Group (Experimental Side): application of a fluoride-releasing composite on the indicated side of the mouth as attachments.

Control Group (Control Side): application of conventional composite as attachments.
3. Aligner Placement: the aligners will be fitted, and patients will wear them continuously, except during eating and brushing.

Outcome Measures:

Primary Outcome: Incidence and Severity of White Spot Lesions Measured at base line, third (T1) and sixth (T2) months.

1.Laser fluorescence (DIAGNOdent), lesion defined as having a numerical score equal to or higher than (14).

Secondary Outcome:

1. Periodontal Ligament (PDL) Health using: Pocket Depth Index (PDI)
2. Gingival Bleeding and Inflammation

Duration of the study:

•This study is suggested to be finished in 12 months.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: